Analysis of HER2 and HER4 in human myocardium to clarify the cardiotoxicity of trastuzumab (Herceptin). (Q47323865)

14 January 2018

title

Analysis of HER2 and HER4 in human myocardium to clarify the cardiotoxicity of trastuzumab (Herceptin). (English)

1 reference

14 January 2018

1 reference

5

1 reference

14 January 2018

author name string

Ilka B Fuchs

1

1 reference

14 January 2018

Solveig Landt

2

1 reference

14 January 2018

Helmut Bueler

3

1 reference

14 January 2018

Uwe Kuehl

4

1 reference

14 January 2018

Anke Kleine-Tebbe

6

1 reference

14 January 2018

Werner Lichtenegger

7

1 reference

14 January 2018

Gerhard Schaller

8

1 reference

14 January 2018

language of work or name

English

0 references

publication date

1 November 2003

1 reference

14 January 2018

Breast Cancer Research and Treatment

published in

1 reference

14 January 2018

volume

82

1 reference

14 January 2018

issue

1

1 reference

14 January 2018

page(s)

23-28

1 reference

14 January 2018

https://scigraph.springernature.com/pub.10.1023/b:brea.0000003916.39959.73

exact match

0 references

cites work

Trastuzumab in the treatment of metastatic breast cancer : anticancer therapy versus cardiotoxicity

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003916.39959.73

Expression of the ERBB3 gene product in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003916.39959.73

Cardiotoxicity in signal transduction therapeutics: erbB2 antibodies and the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003916.39959.73

Neuregulin in Cardiac Hypertrophy in Rats With Aortic Stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003916.39959.73

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003916.39959.73

7 January 2021

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003916.39959.73

7 January 2021

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003916.39959.73

7 January 2021

Retrospective analysis of the safety of Herceptin immunotherapy in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003916.39959.73

7 January 2021

Trastuzumab therapy and the heart: palliation at what cost?

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003916.39959.73

7 January 2021

Requirement for neuregulin receptor erbB2 in neural and cardiac development

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003916.39959.73

7 January 2021

Stress pathways and heart failure

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003916.39959.73

7 January 2021

Neuregulins promote survival and growth of cardiac myocytes. Persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003916.39959.73

7 January 2021

Biological response to ErbB ligands in nontransformed cell lines correlates with a specific pattern of receptor expression

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003916.39959.73

7 January 2021

Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003916.39959.73

7 January 2021

neu tack on neuregulin

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003916.39959.73

7 January 2021

ErbB2 is essential in the prevention of dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003916.39959.73

7 January 2021

Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003916.39959.73

7 January 2021

Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003916.39959.73

7 January 2021

Left ventricular unloading alters receptor tyrosine kinase expression in the failing human heart

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003916.39959.73

7 January 2021

10.1023/B:BREA.0000003916.39959.73

Identifiers

DOI

1 reference

14 January 2018

Dimensions Publication ID

1024652718

0 references

Fatcat ID

release_tkzvseudb5dpzbl4hcn3spjq64

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tkzvseudb5dpzbl4hcn3spjq64

24 November 2022

mapped directly with Wikidata item

PubMed ID

14672400

1 reference

14 January 2018